Answers are grounded in this paper and cite their sources.
Early results of this study suggest that Lenti-D gene therapy may be a safe and effective alternative to allogeneic stem-cell transplantation in boys with early-stage cerebral adrenoleukodystrophy. Additional follow-up is needed to fully assess the duration of response and long-term safety. (Funded by Bluebird Bio and others; STARBEAM ClinicalTrials.gov number, NCT01896102 ; ClinicalTrialsRegister.eu number, 2011-001953-10 .).
No takes yet. Share an insight, caveat, or question.
Eichler et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: